The 2016 World Stem Cell Summit rich program featured a presentation entitled “Our Journey from Autologous to Allogeneic Stem Cell Therapy: How did we get here & when do we use what?” presented by Lou Barnes, Scott P. Bruder, M.D., Ph.D., Timoty Ganey, PhD, and Shabnam M. Namin, PhD, MBA, CTBS
Mr. Bruder, Chairman of the parent company of Amendia, Inc. commented “This summit is the premier opportunity to illuminate and explore the business of regenerative
medicine on a worldwide scale,” “My presentation on allogeneic cells with my colleagues is one of several important and distinguished cell-manufacturing discussions that focus on translation and commercialization for the present and future of
stem cell medicine.”
Over the course of his 25-year career in healthcare, Dr. Bruder has united principles from basic science, clinical medicine, and industrial development to deliver products that enhance patients’ lives and improve outcomes. As a veteran physician, scientist, and executive, he now leads Bruder Consulting International, LLC, providing a variety of services to medical device, biotechnology, and regenerative medicine entities. Currently, he serves as Chairman of the Board of Directors of the parent company of Amendia, Inc., helping to develop biologic implants and medical devices for spine applications.
“Dr. Bruder’s command of the business of regenerative medicine, and influence in healthcare as a whole, is invaluable to the present and future of Amendia’s spine device and biologics innovation,” said Amendia CEO Chris Fair. “We’re honored to have such an insightful luminary on our team.”
Headquartered in a state-of-the-art manufacturing facility in Marietta, Georgia, United States, Amendia is a leading designer, developer, manufacturer and marketer of medical devices used in spinal surgical procedures. Amendia ’s mission is to exceed surgeon and patient expectations by creating balanced solutions with disruptive technologies for medical devices paired with biologics and instrumentation. Amendia ’s vertically-integrated strategy focuses on improving surgical outcomes and the lives of patients with spinal disorders.
